Wide Ranks

ENFN

Enfusion, Inc.

10.02

Top Statistics
Market Cap 945 M Forward PE 34.58 Revenue Growth 15.40 %
Current Ratio 3.62 Trailing PE 250.50 Earnings Growth -27.10 %
Profit Margins 1.70 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 50.99 Enterprise / Revenue 4.84 Price To Sales Trailing12 Months 4.85
Profitability
Profit Margins 1.70 % Operating Margins 5.83 %
Balance Sheet
Total Cash 48 M Total Cash Per Share 0.5120 Total Debt 21 M
Total Debt To Equity 21.97 Current Ratio 3.62 Book Value Per Share 0.7500
All Measures
Short Ratio 226.00 % Message Board Id finmb_179668975 Shares Short Prior Month 1 M
Return On Equity 0.0548 City Chicago Uuid 8d08c37a-82a9-3ef3-8e03-079767279be2
Previous Close 10.13 First Trade Date Epoch Utc 1 B Book Value 0.7500
Beta 0.9340 Total Debt 21 M Volume 313182
Price To Book 13.36 Fifty Two Week Low 7.52 Total Cash Per Share 0.5120
Total Revenue 195 M Shares Short Previous Month Date 1 B Target Median Price 9.70
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins 5.83 %
Target Mean Price 9.61 Net Income To Common 2 M Ask 10.63
Short Percent Of Float 0.0223 Implied Shares Outstanding 94 M Last Fiscal Year End 1 B
Trailing Peg Ratio None Average Daily Volume10 Day 510100 Average Volume10days 510100
Total Cash 48 M Next Fiscal Year End 1 B Revenue Per Share 2.15
Held Percent Insiders 0.0552 Ebitda Margins 9.49 % Trailing PE 250.50
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 10.13
Target Low Price 8.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 9.27
Open 10.17 Free Cashflow 26 M State IL
Dividend Yield 0.00 % Return On Assets 0.0592 Time Zone Short Name EST
Trailing Eps 0.0400 Day Low 9.94 Address1 125 South Clark Street
Shares Outstanding 94 M Price Hint 2 Target High Price 11.00
Website https://www.enfusion.com 52 Week Change -0.0205 Average Volume 405704
Earnings Quarterly Growth -22.60 % Forward Eps 0.2900 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 341.40 % Is_sp_500 False
Regular Market Day High 10.23 Profit Margins 1.70 % Debt To Equity 21.97
Fifty Two Week High 10.45 Day High 10.23 Shares Short 1 M
Regular Market Open 10.17 Industry Key software-application Bid 9.99
Earnings Growth -27.10 % Enterprise To Revenue 4.84 Revenue Growth 15.40 %
Shares Percent Shares Out 0.0108 Operating Cashflow 31 M Currency USD
Time Zone Full Name America/New_York Market Cap 945 M Is_nasdaq_100 False
Zip 60603 Quote Type EQUITY Industry Software - Application
Long Name Enfusion, Inc. Regular Market Day Low 9.94 Held Percent Institutions 0.9678
Current Price 10.02 Address2 Suite 750 Enterprise To Ebitda 50.99
Financial Currency USD Current Ratio 3.62 Gross Margins 67.16 %
Industry Disp Software - Application Number Of Analyst Opinions 8 Country United States
Float Shares 37 M Two Hundred Day Average 8.99 Enterprise Value 944 M
Price To Sales Trailing12 Months 4.85 Forward PE 34.58 Regular Market Volume 313182
Ebitda 18 M Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.

It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services.

Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.